Released on = June 28, 2007, 4:00 am

Press Release Author = Shushmul Maheshwari

Industry = Biotech

Press Release Summary = Asia\'s influence on the global biotech industry is gathering
movement. Owing to this government of each Asian country has invested in
biotechnology, the science of the future.

Press Release Body = Asia\'s influence on the global biotech industry is gathering
movement. Asia’s foray into biotechnology has generated a huge interest in
prospective market players due to the sheer market size that has been unused.

Owing to this government of each Asian country has invested in biotechnology,
considered as science of future and they are basically the ones who are driving the
biotechnology research. In contrast the role played by Private industry is trivial.
This is primarily because biotechnology research requires huge investment in
infrastructure as well as the returns is quite low in the early years.

China’s foray into biotechnology was with a focus on plant genomics and
transgenic technology. It was the Asia’s only country, which took part in the
human genome project. Similarly, India was among the front-runners in biotech
projects and is set to emerge as a strong player in the biopharmaceutical market.

Recent report on “Asia Pacific Biotechnology Market (2007-2010)” by
RNCOS’ also conveyed similar results, as per which, the biotechnology industry
in Asia-Pacific is expected to play a vital role in the global biotechnology market
in future. The Asia-Pacific region generated estimated revenues worth US$ 39.16
Billion in 2006.

The report also confirmed the Asian governments efforts in making biotechnology a
top priority and agreed that the region is largely dependent on the government with
very little private participation in most of the countries.

Likewise the report acknowledged the efforts of China and India (among others) in
the field of biotechnology and talked about the China’s Beijing Genomics
Institute that conducted a number of genome sequencing projects including its
well-publicized human genome project. The report also agreed that over US$ 10
Billion worth of biopharmaceuticals were scheduled to go off patent by the end of
2006 and India, with its unique pharma and biotech skills, can cash in on this
opportunity.

Further, the report also addressed some other interesting issues for today’s
global business environment such as market trends in the Asia-Pacific Biotechnology
industry, the role played by the governments and opportunities that can be leveraged
by the industry.

The report provides an extensive research and objective analysis of the
biotechnology market in Asia-Pacific and help clients in analyzing the opportunities
critical to its growth.

About RNCOS E-Services Pvt Ltd.:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM520.htm
Current Industry News: http://www.rncos.com/blog


Web Site = http://www.rncos.com

Contact Details = RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com